FluoroPharma Medical

FluoroPharma Medical EBIT

The EBIT of FluoroPharma Medical (FPMI) as of Nov 5, 2026 is -2.20 M USD. In the previous year, EBIT was -3.19 M USD — a change of -30.88% (higher).

EBIT

-2.20 MUSD

YoY

-30.88%

Last updated:

In 2016, FluoroPharma Medical's EBIT was -2.20 M USD, a -30.88% increase from the -3.19 M USD EBIT recorded in the previous year.

The FluoroPharma Medical EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2007
-70,336.00 USD
Jan 1, 2008
-13,995.00 USD
Jan 1, 2009
-20,000.00 USD
Jan 1, 2010
-890,000.00 USD
Jan 1, 2013
-4,233.85 USD
Jan 1, 2014
-5,168.84 USD
Jan 1, 2015
-3.19 M USD
Jan 1, 2016
-2.20 M USD
The FluoroPharma Medical EBIT history
YEAREBITYoY
-2.20 MUSD-30.88%
-3.19 MUSD+61,545.17%
-5,168.84USD+22.08%
-4,233.85USD-99.52%
-890,000.00USD+4,350.00%
-20,000.00USD+42.91%
-13,995.00USD-80.10%
-70,336.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

FluoroPharma Medical Revenue

FluoroPharma Medical Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2013
0.00 USD
-4,233.85 USD
-7,284.08 USD
Jan 1, 2014
0.00 USD
-5,168.84 USD
-4,692.06 USD
Jan 1, 2015
0.00 USD
-3.19 M USD
-3.16 M USD
Jan 1, 2016
0.00 USD
-2.20 M USD
-2.05 M USD
Jan 1, 2019
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2020
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2021
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2022
0.00 USD
0.00 USD
0.00 USD

FluoroPharma Medical Margins

FluoroPharma Medical stock margins

The FluoroPharma Medical margin analysis displays the gross margin, EBIT margin, as well as the profit margin of FluoroPharma Medical. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for FluoroPharma Medical.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2013
89.87 %
- %
- %
Jan 1, 2014
89.87 %
- %
- %
Jan 1, 2015
89.87 %
- %
- %
Jan 1, 2016
89.87 %
- %
- %
Jan 1, 2019
89.87 %
0.00 %
0.00 %
Jan 1, 2020
89.87 %
0.00 %
0.00 %
Jan 1, 2021
89.87 %
0.00 %
0.00 %
Jan 1, 2022
89.87 %
0.00 %
0.00 %

FluoroPharma Medical Stock analysis

What does FluoroPharma Medical do? FluoroPharma Medical Inc is an innovative company from the USA that specializes in molecular imaging. It was founded in 2003 and is based in Boston, Massachusetts. The company's goal is to improve the diagnosis and treatment of cardiovascular and cancer diseases. The business model of FluoroPharma Medical is based on the development of radioactive tracers that are used in conjunction with imaging techniques such as PET (Positron Emission Tomography). These tracers are typically administered in the form of radiopharmaceuticals and allow real-time tracking of metabolic processes in the body of patients. The information obtained is used by doctors to make diagnoses and optimize treatment. FluoroPharma Medical specializes in the development of tracers specifically for cardiovascular and cancer diseases. These include the tracer BFPET (up to 3 hours), which is used for the diagnosis of coronary heart disease, and the tracer CardioPET (up to 3 hours), which is used for the diagnosis of cardiovascular diseases. In addition, the company is working on other tracers that are intended for the diagnosis of various types of cancer, such as prostate cancer, breast cancer, and lung cancer. FluoroPharma Medical is divided into different divisions to better organize its activities. The Research and Development division is responsible for the development of new tracers and conducting clinical studies. The Production division is responsible for the manufacturing and distribution of radiopharmaceuticals. Marketing and distribution are handled by the Sales and Marketing division, which works closely with doctors and hospitals. The products of FluoroPharma Medical are currently still in the development phase and not commercially available. However, the company is working closely with various universities and medical facilities to test its tracers in clinical trials. The aim is to demonstrate the effectiveness and safety of the tracers and obtain approval from the FDA (Food and Drug Administration). FluoroPharma Medical has established itself as a pioneer in the field of molecular imaging and is committed to further improving the diagnosis and treatment of cardiovascular and cancer diseases. With its innovative tracers and focus on clinical practice, the company has the potential to significantly improve the medical care of patients in the future. FluoroPharma Medical is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing FluoroPharma Medical's EBIT

FluoroPharma Medical's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of FluoroPharma Medical's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

FluoroPharma Medical's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in FluoroPharma Medical’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about FluoroPharma Medical stock

EBIT of FluoroPharma Medical is -2.20 M USD in 2016.

EBIT of FluoroPharma Medical changed from -3.19 M USD to -2.20 M USD, representing a -30.88% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT FluoroPharma Medical since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's FluoroPharma Medical historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — FluoroPharma Medical

All Key Metrics — FluoroPharma Medical